share_log

Cracking The Code: Understanding Analyst Reviews For QuidelOrtho

Cracking The Code: Understanding Analyst Reviews For QuidelOrtho

破解密碼:理解窺得兒醫藥的分析師評論
Benzinga ·  09/20 05:01
Ratings for QuidelOrtho (NASDAQ:QDEL) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去的三個月中,窺得兒醫藥(納斯達克:QDEL)的評級由4位分析師提供,展示了看好和看淡的觀點混合在一起。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估,下表展示了過去30天內不斷變化的情緒,並將其與之前的幾個月進行了比較。
Analysts have set 12-month price targets for QuidelOrtho, revealing an average target of $57.25, a high estimate of $61.00, and a low estimate of $50.00. Surpassing the previous average price target of $51.00, the current average has increased by 12.25%.
分析師們爲窺得兒醫藥設定了爲期12個月的價格目標,顯示出平均目標爲57.25美元,最高估值爲61.00美元,最低估值爲50.00美元。超過了之前的平均目標價51.00美元,當前的平均值增加了12.25%。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級:詳細剖析
The standing of QuidelOrtho among financial experts becomes clear with a thorough analysis of recent...
通過對最近分析師行動的全面分析...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論